Sarah Owermohle, Politico: The first Covid vaccines were triumphs. What if the next are only OK?
Health experts worry that the public could balk if offered a shot that's only moderately effective.
The nation’s first two coronavirus vaccines smashed scientists’ and health officials’ expectations with roughly 95 percent efficacy and no major safety concerns.
But there aren’t enough doses to go around — and if the next vaccines in the pipeline are merely good instead of great, they could be a hard sell to a skeptical public.
Read more ....
Commentaries, Analysis, And Editorials -- December 30, 2020
How Safe Is Russia’s Sputnik V Coronavirus Vaccine? -- Ethen Kim Lieser, 1945
Why the AstraZeneca vaccine is so important to the global economy -- Charles Riley, CNN Business
Where Year Two of the Pandemic Will Take Us -- Ed Young, The Atlantic
Why Turkey is upgrading its ties with Israel -- MK Bhadrakumar, Asia Times
Why America Should Not Be Involved in Yemen -- Fiona Harrigan, National Interest
Syrian Kurds face betrayal again -- Nikola Mikovic, Asia Times
The Factories in Xinjiang's Forced Labor Camps -- A. Killing & M. Rajagopalan, Buzz Feed
The Coming Global Backlash against China -- Helen Raleigh, National Review
Kim Jong Un faces a new year’s moment of truth -- Daniel Sneider, Asia Times
Expect Missile Testing and Probing From North Korea, Not a Cry For Attention or Help -- Markus V. Garlauskas, National Interest
Uganda sees no end to election-related violence -- Cristina Krippahl, DW
Poor countries avert worst of pandemic, but not its economic fallout -- Christian Science Monitor
With Biden's New Threats, the Russia Discourse is More Reckless and Dangerous Than Ever -- Glenn Greenwald
Biden Risks the Biggest Giveaway Ever to China in Space -- Gordon Chang, The Hill
